Effectiveness outcomes | Mortality n (%) | Morbidity n (%) | HRQoL n (%) | Other n (%) | |
---|---|---|---|---|---|
PtDA with respective outcomes | 33 (46%) | 61 (86%) | 53 (75%) | 16 (23%) | |
Quality of evidence | |||||
High or moderate quevidence | 15 (45%) | 31 (51%) | 17 (32%) | 6 (38%) | |
Low or very low evidence | 18 (55%) | 30 (49%) | 36 (68%) | 10 (62%) |
Harm outcomes | Side effects short term n (%) | Side effects long term n (%) | Complications short term n (%) | Complications long term n (%) | Treatment discontinuation n (%) |
---|---|---|---|---|---|
PtDAS with respective outcomes | 29 (41%) | 11(15%) | 49 (69%) | 32 (45%) | 3 (4%) |
Quality of evidence | |||||
High or moderate evidence | 19 (66%) | 7 (64%) | 20 (40%) | 16 (50%) | 2 (67%) |
Low or very low evidence | 10 (34%) | 4 (36%) | 29 (60%) | 16 (50%) | 1 (33%) |